Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Clémence T. B. Pasmans"'
Autor:
Rick T. van Uum, Roderick P. Venekamp, Clémence T. B. Pasmans, G. Ardine de Wit, Alies Sjoukes, Alma C. van der Pol, Roger A. M. J. Damoiseaux, Anne G. M. Schilder
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Acute otitis media (AOM) is among the most common paediatric conditions managed in primary care. Most recent estimates of the cost of AOM date from a decade ago and lack a full societal perspective. We therefore explored the socie
Externí odkaz:
https://doaj.org/article/98a2c72ae3124236b10ebbfa87e9ed4a
Autor:
G. Ardine de Wit, Roger A M J Damoiseaux, Alies Sjoukes, Anne G M Schilder, Clémence T. B. Pasmans, Roderick P Venekamp, Rick T. van Uum, Alma C van der Pol
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Health Services Research
BMC Health Services Research
Background Acute otitis media (AOM) is among the most common paediatric conditions managed in primary care. Most recent estimates of the cost of AOM date from a decade ago and lack a full societal perspective. We therefore explored the societal cost
Autor:
Edwin Cuppen, Katrien Grünberg, Valesca P. Retèl, Clémence T. B. Pasmans, Veerle M.H. Coupé, Geert W.J. Frederix, Stefan M. Willems, Eiko K. de Jong, Elisabeth M. P. Steeghs, Bastiaan B. J. Tops, Ed Schuuring, Ewart de Bruijn, Marjolijn J. L. Ligtenberg, Hans van Snellenberg
Publikováno v:
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 3, pp. 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor and Francis Ltd.
Pasmans, C T B, Tops, B B J, Steeghs, E M P, Coupé, V M H, Grünberg, K, de Jong, E K, Schuuring, E M D, Willems, S M, Ligtenberg, M J L, Retèl, V P, van Snellenberg, H, de Bruijn, E, Cuppen, E & Frederix, G W J 2021, ' Micro-costing diagnostics in oncology : from single-gene testing to whole-genome sequencing ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 21, no. 3, pp. 413-414 . https://doi.org/10.1080/14737167.2021.1917385
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor & Francis
Expert review of pharmacoeconomics & outcomes research, 21(3), 403-414. Taylor & Francis Group
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor and Francis Ltd.
Pasmans, C T B, Tops, B B J, Steeghs, E M P, Coupé, V M H, Grünberg, K, de Jong, E K, Schuuring, E M D, Willems, S M, Ligtenberg, M J L, Retèl, V P, van Snellenberg, H, de Bruijn, E, Cuppen, E & Frederix, G W J 2021, ' Micro-costing diagnostics in oncology : from single-gene testing to whole-genome sequencing ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 21, no. 3, pp. 413-414 . https://doi.org/10.1080/14737167.2021.1917385
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor & Francis
Expert review of pharmacoeconomics & outcomes research, 21(3), 403-414. Taylor & Francis Group
PurposePredictive diagnostics play an increasingly important role in personalized medicine for cancer treatment. Whole genome sequencing (WGS) based treatment selection is expected to rapidly increase worldwide. Detailed and comparative cost analyses